1. Home
  2. FSTR vs PRQR Comparison

FSTR vs PRQR Comparison

Compare FSTR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

N/A

Current Price

$28.96

Market Cap

270.6M

Sector

Industrials

ML Signal

N/A

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

N/A

Current Price

$2.25

Market Cap

250.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSTR
PRQR
Founded
1902
2012
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
270.6M
250.7M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
FSTR
PRQR
Price
$28.96
$2.25
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$8.14
AVG Volume (30 Days)
29.6K
579.1K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.44
N/A
Revenue
$507,819,000.00
$18,859,556.00
Revenue This Year
$3.42
N/A
Revenue Next Year
$3.88
N/A
P/E Ratio
$65.36
N/A
Revenue Growth
N/A
N/A
52 Week Low
$17.16
$1.07
52 Week High
$29.42
$3.10

Technical Indicators

Market Signals
Indicator
FSTR
PRQR
Relative Strength Index (RSI) 60.05 49.78
Support Level $26.42 $2.15
Resistance Level $29.42 $2.49
Average True Range (ATR) 0.91 0.18
MACD 0.23 0.03
Stochastic Oscillator 71.15 59.13

Price Performance

Historical Comparison
FSTR
PRQR

About FSTR L.B. Foster Company

L.B. Foster Co is a U.S-based firm engaged in the manufacturing, fabrication, and distribution of products and services, especially for the rail, construction, energy, and utility industries. The company operates its business through two segments: Rail Technologies and Services and Infrastructure Solutions. Its principal business activity involves providing new and used rail, trackwork, and accessories, producing concrete railroad ties, insulated rail joints, power rail, track fasteners, cover boards, and sales of sells and rents steel sheet piling, H-bearing pile, and other piling products for foundation and earth retention requirements. It generates the majority of its revenues from the Rail Technologies and Services segment.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: